Structure |
Chemical Name |
CAS |
MF |
|
Meropenem impurity diastereomer 2 |
96035-15-3 |
C15H19N3O5S |
|
Clindamycin Impurity A |
|
|
|
Tigecycline Impurity F |
|
|
|
Fasudil iMpurity A |
|
|
|
Cefminox Impurity C |
|
|
|
Cefazoline Impurity A |
|
|
|
Rifaximin impurity A |
|
|
|
4,5,6,7-Tetrahydro-thieno[3,2-c]pyridin-2-ol 2-acetate |
1151904-85-6 |
C9H11NO2S |
|
ethyl (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
110548-06-6 |
C15H13F2NO4 |
|
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2097505-01-4 |
C56H54N8O7 |
|
Roxithromycin EP Impurity J |
134834-12-1 |
C40H73ClN2O14 |
|
Venlafaxine D6 |
940297-06-3 |
C17H27NO2 |
|
Levosimendan Impurity 3 |
|
|
|
Sofosbuvir Impurity29 |
|
|
|
Acarbose Impurity A |
|
|
|
Levosimendan Impurity 1 |
1643439-59-1 |
C22H23N7O2 |
|
Atomoxetine EP Impurity F |
|
|
|
Quetiapine EP Impurity Q |
|
|
|
Cefoxitin Impurity |
|
|
|
Acemetacin Impurity |
|
|
|
ethyl (S)-6,7,8-trifluoro-1-(1-hydroxypropan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate |
110548-03-3 |
C15H14F3NO4 |
|
ethyl (E)-2-(2-(4-methoxyphenyl)hydrazono)propanoate |
4792-57-8 |
C12H16N2O3 |
|
ACT 373898 |
1433875-14-9 |
C15H17BrN4O5S |
|
Reaxys ID: 3623864 |
129385-61-1 |
C17H10ClNO3 |
|
Olaparib Impurity D |
|
|
|
1-methylpyrrolidin-3-yl 2-(cyclopentyloxy)-2-phenylacetate |
|
C18H25NO3 |
|
Cabozantinib impurity A |
|
|
|
Loratadine Impurity 2 |
|
C22H23ClN2O2 |
|
Metoprolol Impurity 1 |
|
C15H25NO3 |
|
Pitavastatin Impurity 1 |
|
|
|
Trifluridine Impurity 3 |
|
|
|
Vonoprazan Impurity 1 |
|
|
|
Vonoprazan Impurity 4 |
|
|
|
Cinacalcet impurity K |
|
|
|
Valsartan Impurity 13 |
|
C24H29N5O3 |
|
Valsartan Impurity 27 |
|
C24H29N5O3 |
|
Etoricoxib Impurity 6 |
|
|
|
Ezetimibe impurity 3 |
|
|
|
Apremilast Impurity C |
|
|
|
bis(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
166808-97-5 |
C16H16N2O6 |
|
Ticagrelor Imp.J |
2248538-63-6 |
C14H20ClN5O4S |
|
Vortioxetine Imp.E |
508233-77-0 |
C18H22N2S |
|
(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-07-6 |
C25H24FNO3 |
|
Topiroxostat Impurity 1 |
|
|
|
Oxcarbazepine Impurity3 |
|
|
|
Mosapride IMP |
|
|
|
4-Ethoxy Paroxetine |
606968-04-1 |
C21H25NO4 |
|
Methylene-Bis Paroxetine |
1292846-10-6 |
C39H40F2N2O6 |
|
Trelagliptin Impurity X |
1938080-44-4 |
C18H22FN5O3 |
|
Afatinib Impurity 19 |
1245555-42-3 |
C21H21ClFN5O2 |
|
Cefoxitin Sodium impurity |
|
|
|
(1S,2S,3S)-Aprepitant |
1242175-40-1 |
C23H21F7N4O3 |
|
2-{[(methoxycarbonylmethyl)(toluene-4-sulfonyl)amino]methyl}-4-phenoxybenzoic acid methyl ester |
1455091-06-1 |
C25H25NO7S |
|
2-Desisopropyl-2-phenyl Repaglinide |
107362-12-9 |
C30H34N2O4 |
|
2-(3-CHLOROPHENYL)-2-CYANO-1-(3-PYRIDINYL)-1-ETHANONE |
114444-10-9 |
C14H9ClN2O |
|
BENZENE ACETIC ACID, 4-[(2-CARBOXYPHENYL)METHOXY] |
55453-89-9 |
C16H14O5 |
|
Ipragliflozin Impurity 5 |
|
|
|
Alectinib Impurity |
1256584-83-4 |
C26H25N3O2 |
|
Afatinib impurity 11/Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib |
2223677-58-3 |
C22H20ClFN4O4 |
|
Ibrutinib Impurity 18 |
1881246-01-0 |
C16H12N4O |
|
Vitamin B1 Impurity 6 |
|
C12H17ClN4OS |
|
5,5'-((tert-butylazanediyl)bis(1-hydroxyethane-2,1-diyl))bis(benzene- 1,3-diol) |
|
C20H27NO6 |
|
2,2'-difluoro-3,3'-dimethoxy-1,1'-biphenyl |
2316733-82-9 |
C14H12F2O2 |
|
nicergoline impurity N |
|
|
|
Clopidogrel Impurity 50 |
|
C15H14ClNO2S |
|
PraMipexole IMpurity Z1/Z2 |
|
|
|
trans-Ibuprofen Impurity G |
|
C13H18O2 |
|
Vonoprazan Impurity 15 |
|
|
|
Esomeprazole Impurity 6 |
|
|
|
Erlotinib Impurity 22 |
|
|
|
Teneligliptin Impurity 1 |
|
|
|
Erlotinib Hydrochloride iMpurity 51 |
|
|
|
(S)-10-(1-aminocyclopropyl)-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid formic acid |
|
C17H18N2O6 |
|
1H-Imidazole-1-ethanol, α-(chloromethyl)-5-nitro- |
116989-52-7 |
C6H8ClN3O3 |
|
4-Pyridinemethanol, 3-hydroxy-2,5-dimethyl-, hydrochloride (1:1) |
875-26-3 |
C8H11NO2.ClH |
|
Afatinib ImpurityOYQ |
|
|
|
Androst-3-en-17-one,(5) |
14935-81-0 |
C19H28O |
|
Landiolol impurity X |
|
|
|
2-((4-(3-aminopiperidin-1-yl) |
|
|
|
Rosuvastatin Impurity 111 |
|
|
|
Metoprolol IMpurity V |
|
C15H25NO3 |
|
Teneligliptin Impurity 12 |
|
|
|
Nicergoline EP Impurity E |
|
|
|
Hexanoic acid, 3-[(hydroxyamino)methyl]-5-methyl-, (3S)- |
2349671-57-2 |
C8H17NO3 |
|
α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate |
714269-58-6 |
C30H35ClO11 |
|
Caspofungin Impurity H |
|
|
|
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine hydrochloride |
127017-41-8 |
C21H26ClNO4 |
|
Ezetimibe Impurity 76 |
1185883-46-8 |
C39H44F2N2O5Si |
|
Cefmetazole impurity 9/(6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-3-(hydroxymethyl)-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid |
70953-19-4 |
C13H15N3O6S2 |
|
((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate |
|
C20H24FNO3S |
|
Elagolix Sodium impurity1 |
|
|
|
Ibrutinib Impurity 37 |
330793-49-2 |
C10H13IN6 |
|
(S)-((6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol |
|
C11H19N3OS |
|
(trans)-4-((6-amino-2,3-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
ERYTHROMYCIN IMPURITY N |
|
|
|
Fesoterodine Impurity 12 |
|
|
|
Dexamethasone EP impurities D |
|
|
|
Palbociclib impurity LMAP |
|
|
|
(3R,3'R)-3,3'-((((S)-1-amino-1-oxobutan-2-yl)azanediyl)bis(methylene))dihexanoic acid |
|
C18H34N2O5 |
|
Acetaminophen EP Impurity L |
|
C8H9NO2 |